Abstract
Escherichia coli is an important cause of severe community acquired pneumonia with mortality higher than pneumococcal pneumonia but like other gram-negative pneumonia. Antibiotics are the treatment of choice in treating pneumonia. When it comes to bacterial community-acquired pneumonia, multidrug resistant Escherichia coli (MDR E. Coli) is a less common cause than Staphylococcus aureus and Streptococcus pneumoniae. The majority of patients with community-acquired pneumonia (CAP) respond well to typical antibiotic regimens consisting of either a fluoroquinolone or a macrolide plus cephalosporin. We present a case where patient diagnosed with E. coli causing pneumonia showed MDR to various empirical antibiotics and managed with culture sensitive antibiotics. Antibiotic resistance has become a major issue for healthcare providers, where the effective management of patients will be more challenging which necessitates the need for optimising the use of antibiotics. Keywords: Multi Drug Resistance, Community Acquired Pneumonia, Escherichia Coli, Cholangiocarcinoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
